Results 171 to 180 of about 22,319 (215)

Integritas Ilmu dalam Perpekstif Pendidikan

JURNAL PENELITIAN, 2015
openaire   +2 more sources

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis. [PDF]

Nat Genet
Boesch M, Anak S, El Abyad D, Ostyn T, Antoranz A, My Van T, Newhouse D, Myers C, Van Melkebeke L, Palmer J, Saffarzadeh N, Chui JS, Feio-Azevedo R, Smets L, Shankar G, Dubroja Lakić N, Calvo PL, Voet T, Clark J, Cockell S, Lannoo M, Deleus E, Jaekers J, Topal H, Topal B, Schneider KM, Vacca M, Allison M, Ekstedt M, Boursier J, Bugianesi E, Ratziu V, De Smet F, Boeckx B, Daly AK, Schattenberg JM, Verbeek J, Bosisio F, Lambrechts D, Roskams T, Schneider CV, Francque S, Korf H, Härtlova A, Tiniakos D, Anstee QM, van der Merwe S, Govaere O.   +47 more
europepmc   +1 more source

CONQUEST-ADVANCE: Achieving proDuctiVe implementAtioN of CONQUEST Quality Standards in COPD Care. [PDF]

Pragmat Obs Res
Vijaykumar E, Gatenby J, Evans A, Henley W, Eleangovan N, Couper A, Kerr M, Ariti C, Busby J, Alves L, Bafadhel M, Bhutani M, Carter V, Chen R, Chalmers J, Crooks MG, Devereux G, Dickens AP, Freeman D, Gale CP, Gibson JM, Halpin D, Hickman K, Hurst JR, Marshall J, Martinez FJ, Miravitlles M, Mullerova H, Morris T, Muro S, Natman J, Quint JK, Sharma A, Singh D, Singh M, Stolz D, Pullen R, Varghese D, Wilkinson TM, Winders T, Price D.   +40 more
europepmc   +1 more source

Characterization of Patients with COPD and GOLD E Classification in the United States. [PDF]

Int J Chron Obstruct Pulmon Dis
Bhatt SP, Zhang Y, White J, Stanford RH, Mayen Herrera E, Cunoosamy D, Djandji M, Soliman M, Qureshi T, Subramaniam A.   +9 more
europepmc   +1 more source

Win Ratio Analysis to Clarify Clinical Benefits: A Post Hoc Analysis of Phase 3 BOREAS and NOTUS (Two Pivotal Studies to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-Severe COPD With Type 2 Inflammation). [PDF]

Chest
Ramakrishnan S, Petousi N, Bon J, Pavord ID, Bhatt SP, Rabe KF, Deng W, Xia C, Heble J, Soliman M, Couillard S.   +10 more
europepmc   +1 more source

COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. [PDF]

Microbiol Spectr
Habtehyimer F, Zhu X, Redd AD, Gebo KA, Abraham AG, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Oei KS, Cluzet V, Cordisco ME, Greenblatt B, Rausch W, Shade D, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ.   +46 more
europepmc   +1 more source

Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial. [PDF]

Lancet Reg Health Am
Falade-Nwulia O, Price JC, Feld JJ, Eaton E, Franco RA, Barnaba B, Brown D, Hussain S, Verinumbe T, Wren C, Karimi-Sari H, Hirose K, Cavacuiti C, O'rear ST, Capraru C, Tobin K, Vaidya D, Schwartz S, Sulkowski M.   +18 more
europepmc   +1 more source

Exploring COPD Participants' Experiences in a Comprehensive Telewellness Program within a Mixed-Disability Cohort: A Qualitative Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Arora P, Bhatt SP, Rimmer JH.
europepmc   +1 more source

The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort. [PDF]

ERJ Open Res
Agustí A, Hughes R, Rapsomaki E, Make B, Del Olmo R, Papi A, Price D, Benton L, Franzen S, Vestbo J, Mullerova H.   +10 more
europepmc   +1 more source